In This Article:
As global markets grapple with economic slowdown worries and the S&P 500 Index experiences its sharpest weekly decline in 18 months, small-cap stocks are not immune to these broader market sentiments. With fewer job openings signaling a weakening U.S. labor market and heightened investor nervousness, identifying undervalued opportunities becomes crucial. In such a volatile environment, stocks that exhibit strong fundamentals combined with insider buying can present compelling investment opportunities.
Top 10 Undervalued Small Caps With Insider Buying
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
Bytes Technology Group | 22.9x | 5.2x | 18.73% | ★★★★★☆ |
Essentra | 771.1x | 1.5x | 42.70% | ★★★★★☆ |
Genus | 160.2x | 1.9x | 2.21% | ★★★★★☆ |
Delek US Holdings | NA | 0.1x | 22.88% | ★★★★★☆ |
CVS Group | 22.8x | 1.3x | 40.27% | ★★★★☆☆ |
Primaris Real Estate Investment Trust | 12.3x | 3.3x | 40.66% | ★★★★☆☆ |
German American Bancorp | 13.7x | 4.6x | 47.35% | ★★★☆☆☆ |
MYR Group | 31.5x | 0.4x | 47.17% | ★★★☆☆☆ |
Studsvik | 20.3x | 1.2x | 42.39% | ★★★☆☆☆ |
Community West Bancshares | 18.7x | 2.9x | 42.25% | ★★★☆☆☆ |
We'll examine a selection from our screener results.
Tabcorp Holdings
Simply Wall St Value Rating: ★★★★★☆
Overview: Tabcorp Holdings operates in gaming services and wagering and media, with a market cap of approximately A$4.38 billion.
Operations: Tabcorp Holdings generates revenue primarily from Wagering and Media ($2.16 billion) and Gaming Services ($176.1 million). The company has seen fluctuations in its net income margin, with a notable drop to -57.63% as of September 2024. Operating expenses have remained significant, often surpassing $2 billion annually, impacting overall profitability despite consistently high gross profit margins of 100%.
PE: -0.7x
Tabcorp Holdings, a small-cap stock, has seen significant insider confidence with share purchases in the last quarter. Despite reporting a net loss of A$1.36 billion for the year ending June 30, 2024, compared to net income of A$66.5 million the previous year, earnings are forecasted to grow by 117.91% annually. The company’s recent dividend decrease to A$0.003 per share and its reliance on external borrowing highlight both challenges and potential for future growth in this sector.
-
Navigate through the intricacies of Tabcorp Holdings with our comprehensive valuation report here.
-
Review our historical performance report to gain insights into Tabcorp Holdings''s past performance.
Genus
Simply Wall St Value Rating: ★★★★★☆
Overview: Genus is a biotechnology company focused on animal genetics, with operations in bovine and porcine sectors, and has a market cap of £2.50 billion.